** Shares of China's WuXi Biologics 2269.HK fall 5.9% to HK$15.62, on track for their biggest one-day pct drop since Oct 15 if current losses hold
** Stock hits the lowest level since Dec 3 on its second straight session of decline; second-biggest pct loser in the Hang Seng Index .HSI, which slips 0.6%
** Co said on Monday it would sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co MRK.N for about $500 mln, ahead of potential U.S. legislation that would restrict business for Chinese biotech companies
** The U.S. House of Representatives passed the Biosecure Act in September, which would ban federal contracts with targeted firms and their business partners
** The Hang Seng Commerce & Industry Index .HSNC eases 0.8% and the healthcare index .HSCIH declines 0.7%
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。